NYC Cop On His Own For Pepper Spraying

Anthony Bologna, a man infamous among Occupy Wall Street protesters, who even warranted the nickname, Tony Baloney, is being sued for pepper spraying a crowd of protesters on September 24,...

Core Firm in Settlement Wants Their Share of Apple Pie

We want a slice

We recently wrote about how a Chinese tech company won a settlement against Apple to the tune of $60 million over its iPad trademark. However, when it comes to paying the law firm that helped them earn that paycheck, Proview seems to be skipping out on the bill. The Grandall Law Firm is suing for their agreed-upon share of the settlement, which comes out to $2.4 million. Proview founder Yang Rongshan has been quoted as saying the complaints by the firm are “nonsense” and has insisted that they will be paying the bill eventually. The company itself is rumored to be in the process of liquidation due to impending bankruptcy, lending some insight to Grandall Law’s insistence on being paid as soon as possible. 

Middle Finger to the Law

"Cops keep firing in my environment / middle finger to the law."  These immortal words from New York rapper Nas were most likely running through Robert Bell's head on August...

The End of Penn State

We Are…

Without question, the Jerry Sandusky child abuse case has completely turned Penn State University on its head. With the recent discovery that head football coach Joe Paterno had tried to sweep the entire molestation issue under the rug, the prestigious and now-infamous institution is now dealing with a deluge of lawsuits that will plague them for years to come.  From the courtroom to the football field, and all the places between, early estimations show that the settlements could reach the $100 million mark as more victims come forward.

Women Seeking Relief from Menopause Get Breast Cancer

Six million women have settled with Pfizer Inc over side effects from their menopause drug Prempro. The class action lawsuit alleged that Pfizer downplayed the risk of side effects or misinformed its customers about them, leading many users of the drug to develop breast cancer.